Hamid Latifi-Navid is Head of the Bioinformatics Department at Asu vanda Gene Industrial Research Company (through Asu Scientific Club platform). He also is a PhD candidate in molecular genetics from the National
Institute of Genetic Engineering and Biotechnology, Tehran, Iran. His research
field is to design novel multi-target anti-angiogenic molecules and evaluate their function in the newborn mice eyes. Drug resistance in these molecules occurs slower than conventional therapeutic approaches. Moreover, He is interested in biological network analysis, computer-aided drug design, and artificial intelligence in drug discovery and development.